Compound 201 995,
Compound 201-995,
Compound 201995,
Octreotide,
Octreotide Acetate,
Octreotide Acetate Salt,
SAN 201 995,
SAN 201-995,
SAN 201995,
Sandostatin,
Sandostatine,
Sandoz 201 995,
Sandoz 201-995,
Sandoz 201995,
SM 201 995,
SM 201-995,
SM 201995,
SMS 201 995,
SMS 201-995,
SMS 201995,
Octreotide acetate,
79517-01-4,
Sandostatin LAR,
Sandostatin,
Longastatin,
SMS 201-995 AC,
Octreolin,
Longastatina,
Sandostatine,
Sandostatin LAR Depot,
Octeotride SDI,
Octreotide LAR,
Longastatina LAR,
Octreotide acetate [USAN:JAN],
AC1OCEUW,
OCTREOIDE ACETATE,
Octreotide Acetate Depot,
NSC-685403,
SMS 201995,
C49H66N10O10S2.C2H4O2,
CCRIS 8708,
CHEMBL1200480,
UNII-75R0U2568I,
SMS-995,
VAP-003,
XQEJFZYLWPSJOV-XJQYZYIXSA-N,
SMS-201-995 AC,
3944AH,
MFCD08277638,
VP-003,
AKOS030485976,
Octreotide acetate (preservative free),
75R0U2568I,
SMS-201995,
D-Phenylalanyl-L-cysteinyl-L-phenylalanyl-D-tryptophyl-L-lysyl-L-threonyl-N-((1R,2R)-2-hydroxy-1-(hydroxymethyl)propyl)-L-cysteinamide cyclic (2->7)-disulfide acetate (salt),
D-Phenylalanyl-L-cysteinyl-L-phenylalanyl-D-tryptophyl-L-lysyl-L-threonyl-N-((1R,2R)-2-hydroxy-1-(hydroxymethyl)propyl)-L-cysteinamide cyclic (2-7)-disulfide acetate (salt),
D-Phenylalanyl-L-hemicystyl-L-phenylalanyl-D-tryptophyl-L-lysyl-L-threonyl-L-hemicystyl-L-threoninol cyclic (2->7)-disulfide acetate (salt),
D-Phenylalanyl-L-hemicystyl-L-phenylalanyl-D-tryptophyl-L-lysyl-L-threonyl-L-hemicystyl-L-threoninol cyclic (2-7)-disulfide acetate (salt),
L-Cysteinamide, D-phenylalanyl-L-cysteinyl-L-phenylalanyl-D-tryptophyl-L-lysyl-L-threonyl-N-(2-hydroxy-1-(hydroxymethyl)propyl)-, cyclic (2-7)-disulfide, (R-(R*,R*))-, acetate (salt),
L-Cysteinamide, D-phenylalanyl-L-cysteinyl-L-phenylalanyl-D-tryptophyl-L-lysyl-L-threonyl-N-(2-hydroxy-1-(hydroxymethyl)propyl)-, cyclic(2-7)-disulfide, (R-(R*,R*))-, acetate (salt),
517O014,
(4R,7S,10S,13R,16S,19R)-13-((1H-indol-3-yl)methyl)-19-((R)-2-amino-3-phenylpropanamido)-10-(4-aminobutyl)-16-benzyl-N-((2R,3R)-1,3-dihydroxybutan-2-yl)-7-((R)-1-hydroxyethyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentaazacycloicosane-4-carboxamide acetate,
acetic acid,10-(4-aminobutyl)-19-[(2-amino-3-phenylpropanoyl)amino]-16-benzyl-N-(1,3-dihydroxybutan-2-yl)-7-(1-hydroxyethyl)-13-(1H-indol-3-ylmethyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentazacycloicosane-4-carboxamide,
acetic acid; (4R,7S,10S,13R,16S,19R)-10-(4-aminobutyl)-19-[[(2R)-2-amino-3-phenylpropanoyl]amino]-16-benzyl-N-[(2R,3R)-1,3-dihydroxybutan-2-yl]-7-[(1R)-1-hydroxyethyl]-13-(1H-indol-3-ylmethyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentazacycloicosane-4-carboxamide,
C2L,
L-Cysteinamide,D-phenylalanyl-L-cysteinyl-L-phenylalanyl-D-tryptophyl-L-lysyl-L-threonyl-N-[(1R,2R)-2-hydroxy-1-(hydroxymethyl)propyl]-, cyclic (27)-disulfide,acetate (salt),
Octreotide,
D00TIG,
RG3806,
ACN-057306,
CID6917964,
CS-T-59870,
SMS 201-995,
2226S,
83150-76-9,
(4R,7S,10S,13R,16S,19R)-13-((1H-Indol-3-yl)methyl)-19-((R)-2-amino-3-phenylpropanamido)-10-(4-aminobutyl)-16-benzyl-N-(1,3-dihydroxybutan-2-yl)-7-((R)-1-hydrox,